Germany Life Sciences Update - Spotlight: Pharmaceutical Pricing & Reimbursement

We cordially invite you to join our next “Germany Life Sciences Update”. This webinar will cover “Pharmaceutical Pricing & Reimbursement“ (P&R). We will describe how the German P&R system works, highlight hot topics and discuss upcoming legal changes. A special focus will be the current reform bill GKV-Beitragssatzstabilisierungsgesetz (GKV-BStabG). We will address how this highly controversial reform will impact pharmaceutical companies.

Topics covered and questions answered will include:  

• Overview of the German drug pricing & reimbursement system
• AMNOG: market access with mandatory benefit assessment and price negotiations for new drugs
• How will the GKV-BStabG impact pharmaceutical companies?
• New cost-containment and pricing measures. And, will there be waivers in case of national clinical trials and production?
• Interplay of AMNOG and JCAs under EU HTA
• The German system and U.S. Most-Favored-Nation (MFN) pricing – harmony or conflicts?

For more information on the continuing reforms, ahead of our webinar, please read the team’s recent blog post here.

Event Details

Wednesday, September 9th, 2026
4:00 - 5:00 p.m. CEST

Log-in details will be provided upon registration.

By Invitation Only

This event is closed to the press and to professionals from other law firms.